Ceftaroline is an antibiotic used to treat infections caused by certain bacteria. It's often used for skin infections, especially in adults and newborns. It helps stop the growth of harmful bacteria.
Every report comes from a Lived member, sent anonymously.
No reports yet
Add what worked for you with the search bar below
Ceftaroline, sold in the US as Teflaro (and in Europe as Zinforo), is an intravenous antibiotic used in hospitals and infusion settings. It is approved for two kinds of bacterial infection: serious skin infections, such as spreading cellulitis, abscesses and infected wounds, and pneumonia that a person catches in the community rather than in a hospital. Both uses apply to adults and to children, with skin infections approved down to newborns of at least 34 weeks gestation and 12 days after birth, and pneumonia from 2 months of age. Ceftaroline belongs to the cephalosporins, a large family of antibiotics related to penicillin. What sets it apart is that it can kill MRSA (methicillin-resistant Staphylococcus aureus), a staph germ that resists most penicillin-type and cephalosporin antibiotics. Its US approval covers MRSA in skin infections; for pneumonia, the approval covers staph that is not resistant, along with common pneumonia bacteria. Doctors sometimes also use it, off label, for MRSA bloodstream infections, often alongside vancomycin or daptomycin, two other antibiotics used for serious staph infections.
Bacteria are protected by a rigid cell wall, which they build with enzymes called penicillin-binding proteins. Cephalosporins attach to these enzymes and stop the wall from being assembled properly, so the bacteria break apart and die. MRSA resists most of these antibiotics because it makes an altered version of the enzyme, called PBP2a, that older drugs cannot grip. Ceftaroline binds PBP2a well, which is why it works against MRSA when its relatives do not. It does not, however, work against many hospital-acquired gut bacteria that make enzymes able to break down cephalosporins, so it is not a catch-all antibiotic. The drug is given as ceftaroline fosamil, an inactive form that dissolves well in fluid. Once in the bloodstream, the body quickly converts it to active ceftaroline.
Ceftaroline is given only as an intravenous (IV) infusion, a slow drip into a vein, which usually takes 5 to 60 minutes. Adults typically receive a dose every 12 hours. For adults with a skin infection, the label calls for 5 to 14 days; the length for pneumonia also depends on how the infection responds. Children's doses are based on age and weight and may be given every 8 hours. Because the kidneys clear ceftaroline from the body, the dose is lowered for people with reduced kidney function, including those on dialysis. Older adults often have lower kidney function even without kidney disease, so the care team checks it before choosing a dose. There is no pill form; if a person is ready to leave the hospital before the course is finished, the team may switch to an antibiotic taken by mouth or arrange IV treatment at home or at an infusion center.
Most people tolerate ceftaroline well. The most common side effects are diarrhea, nausea and rash. Some people get soreness, redness or irritation along the vein used for the infusion, which the nursing team can usually manage by changing the IV site. Antibiotics can disrupt the normal bacteria of the gut and allow an infection called Clostridioides difficile (C. diff) to take hold. Contact the care team promptly about severe watery diarrhea or diarrhea with blood, even if it starts weeks after the antibiotic has ended; C. diff can appear more than two months later. Rarely, ceftaroline has caused confusion, unusual drowsiness, slowed thinking or seizures, mostly in people whose kidney function was reduced and whose dose was not lowered. These changes have reversed once the drug was stopped or removed by dialysis, and they should be reported to the care team at once. Serious allergic reactions are uncommon but can be life threatening. Trouble breathing, swelling of the face or throat, or widespread hives need immediate treatment: tell the nurse at once during an infusion, or call 911 if this happens away from medical care.
People who have had a serious allergic reaction to ceftaroline or to any other cephalosporin should not receive it. Allergy to penicillin or to carbapenems (another related antibiotic family) does not automatically rule it out, but people allergic to one of these drugs can react to the others, so the team needs the details of any past reaction to decide whether ceftaroline is safe and how closely to watch during treatment. Ceftaroline has few known drug interactions. It is not processed by the liver enzymes that cause many common interactions, although no formal interaction studies have been done in people. It should not be mixed in the same IV line or bag with other medicines. Ceftaroline can make a blood test called the direct Coombs test turn positive, which matters mainly if a transfusion is needed or if anemia (a low red blood cell count) develops during or after treatment; in that case doctors check whether the drug is destroying red blood cells. There are no adequate studies in pregnancy; animal studies did not show harm to the developing baby. It is not known whether ceftaroline passes into breast milk. Anyone pregnant or breastfeeding should weigh the need for this antibiotic against alternatives with the care team.
Ceftaroline is usually started in the hospital, sometimes before lab results confirm which bacteria are responsible. Samples from the wound, blood or sputum are often sent for culture, and once results come back the team may continue ceftaroline, switch to a narrower antibiotic, or change course if the germ is not susceptible. The first few days show whether treatment is working. In the main adult trials, about three in four people with serious skin infections had no fever and no further spread of redness by day 3, and about seven in ten people with pneumonia were stable with improving symptoms by day 4. Once someone is clearly improving, the team may switch to antibiotic pills; if there is little change, it will usually reassess the diagnosis, whether an abscess needs draining, and the antibiotic choice. It matters to complete the planned course even after feeling better, because stopping early can let the infection return and encourages bacteria to become resistant. For MRSA bloodstream infections, where ceftaroline is sometimes added to standard treatment, recent reviews have not found that it improves survival compared with vancomycin or daptomycin alone, so its use there is a judgment call for infection specialists.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Ceftaroline, what you've noticed, or ask the community a question.